nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCC1—Vinblastine—head and neck cancer	0.219	0.23	CbGbCtD
Amprenavir—ABCC1—Docetaxel—head and neck cancer	0.18	0.189	CbGbCtD
Amprenavir—CYP2D6—Hydroxyurea—head and neck cancer	0.141	0.147	CbGbCtD
Amprenavir—CYP2C8—Fluorouracil—head and neck cancer	0.0842	0.0883	CbGbCtD
Amprenavir—CYP3A5—Docetaxel—head and neck cancer	0.0669	0.0701	CbGbCtD
Amprenavir—CYP2C9—Fluorouracil—head and neck cancer	0.0587	0.0616	CbGbCtD
Amprenavir—ABCB1—Vinblastine—head and neck cancer	0.0528	0.0554	CbGbCtD
Amprenavir—CYP2D6—Vinblastine—head and neck cancer	0.0497	0.0522	CbGbCtD
Amprenavir—ABCB1—Docetaxel—head and neck cancer	0.0435	0.0456	CbGbCtD
Amprenavir—CYP3A4—Vinblastine—head and neck cancer	0.0316	0.0332	CbGbCtD
Amprenavir—CYP3A4—Docetaxel—head and neck cancer	0.0261	0.0274	CbGbCtD
Amprenavir—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.00211	0.0656	CcSEcCtD
Amprenavir—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.00152	0.0472	CcSEcCtD
Amprenavir—Inflammation—Fluorouracil—head and neck cancer	0.00092	0.0286	CcSEcCtD
Amprenavir—Depression—Vinblastine—head and neck cancer	0.000758	0.0236	CcSEcCtD
Amprenavir—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000749	0.0233	CcSEcCtD
Amprenavir—Myocardial infarction—Vinblastine—head and neck cancer	0.000745	0.0232	CcSEcCtD
Amprenavir—Neutropenia—Hydroxyurea—head and neck cancer	0.000727	0.0226	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.000708	0.022	CcSEcCtD
Amprenavir—Inflammation—Docetaxel—head and neck cancer	0.000664	0.0206	CcSEcCtD
Amprenavir—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000656	0.0204	CcSEcCtD
Amprenavir—Discomfort—Vinblastine—head and neck cancer	0.0005	0.0155	CcSEcCtD
Amprenavir—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000492	0.0153	CcSEcCtD
Amprenavir—Myocardial infarction—Fluorouracil—head and neck cancer	0.000489	0.0152	CcSEcCtD
Amprenavir—Anorexia—Vinblastine—head and neck cancer	0.000462	0.0144	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000458	0.0142	CcSEcCtD
Amprenavir—Discomfort—Hydroxyurea—head and neck cancer	0.000456	0.0142	CcSEcCtD
Amprenavir—Paraesthesia—Vinblastine—head and neck cancer	0.000435	0.0135	CcSEcCtD
Amprenavir—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000434	0.0135	CcSEcCtD
Amprenavir—Liver function test abnormal—Docetaxel—head and neck cancer	0.000432	0.0134	CcSEcCtD
Amprenavir—Skin disorder—Hydroxyurea—head and neck cancer	0.00043	0.0134	CcSEcCtD
Amprenavir—Anorexia—Hydroxyurea—head and neck cancer	0.000421	0.0131	CcSEcCtD
Amprenavir—Decreased appetite—Vinblastine—head and neck cancer	0.000421	0.0131	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000421	0.0131	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000412	0.0128	CcSEcCtD
Amprenavir—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000396	0.0123	CcSEcCtD
Amprenavir—Decreased appetite—Hydroxyurea—head and neck cancer	0.000384	0.012	CcSEcCtD
Amprenavir—Abdominal pain—Vinblastine—head and neck cancer	0.000383	0.0119	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000382	0.0119	CcSEcCtD
Amprenavir—Fatigue—Hydroxyurea—head and neck cancer	0.000381	0.0119	CcSEcCtD
Amprenavir—Neutropenia—Docetaxel—head and neck cancer	0.000378	0.0117	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000357	0.0111	CcSEcCtD
Amprenavir—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000355	0.011	CcSEcCtD
Amprenavir—Myocardial infarction—Docetaxel—head and neck cancer	0.000353	0.011	CcSEcCtD
Amprenavir—Asthenia—Vinblastine—head and neck cancer	0.000348	0.0108	CcSEcCtD
Amprenavir—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000341	0.0106	CcSEcCtD
Amprenavir—Myalgia—Fluorouracil—head and neck cancer	0.000332	0.0103	CcSEcCtD
Amprenavir—Diarrhoea—Vinblastine—head and neck cancer	0.000332	0.0103	CcSEcCtD
Amprenavir—Discomfort—Fluorouracil—head and neck cancer	0.000328	0.0102	CcSEcCtD
Amprenavir—Connective tissue disorder—Docetaxel—head and neck cancer	0.000318	0.00988	CcSEcCtD
Amprenavir—Asthenia—Hydroxyurea—head and neck cancer	0.000317	0.00987	CcSEcCtD
Amprenavir—Nervous system disorder—Fluorouracil—head and neck cancer	0.000312	0.00971	CcSEcCtD
Amprenavir—Vomiting—Vinblastine—head and neck cancer	0.000308	0.00959	CcSEcCtD
Amprenavir—Erythema multiforme—Docetaxel—head and neck cancer	0.000306	0.00951	CcSEcCtD
Amprenavir—Headache—Vinblastine—head and neck cancer	0.000304	0.00945	CcSEcCtD
Amprenavir—Anorexia—Fluorouracil—head and neck cancer	0.000303	0.00944	CcSEcCtD
Amprenavir—Diarrhoea—Hydroxyurea—head and neck cancer	0.000303	0.00941	CcSEcCtD
Amprenavir—Cardiac disorder—Docetaxel—head and neck cancer	0.0003	0.00933	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00029	0.00902	CcSEcCtD
Amprenavir—Nausea—Vinblastine—head and neck cancer	0.000288	0.00896	CcSEcCtD
Amprenavir—Paraesthesia—Fluorouracil—head and neck cancer	0.000286	0.00889	CcSEcCtD
Amprenavir—Mental disorder—Docetaxel—head and neck cancer	0.000283	0.00881	CcSEcCtD
Amprenavir—Malnutrition—Docetaxel—head and neck cancer	0.000281	0.00875	CcSEcCtD
Amprenavir—Vomiting—Hydroxyurea—head and neck cancer	0.000281	0.00874	CcSEcCtD
Amprenavir—Rash—Hydroxyurea—head and neck cancer	0.000279	0.00867	CcSEcCtD
Amprenavir—Dermatitis—Hydroxyurea—head and neck cancer	0.000279	0.00866	CcSEcCtD
Amprenavir—Headache—Hydroxyurea—head and neck cancer	0.000277	0.00861	CcSEcCtD
Amprenavir—Decreased appetite—Fluorouracil—head and neck cancer	0.000277	0.0086	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000275	0.00855	CcSEcCtD
Amprenavir—Nausea—Hydroxyurea—head and neck cancer	0.000263	0.00817	CcSEcCtD
Amprenavir—Myalgia—Docetaxel—head and neck cancer	0.00024	0.00745	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000238	0.0074	CcSEcCtD
Amprenavir—Nervous system disorder—Docetaxel—head and neck cancer	0.000225	0.00701	CcSEcCtD
Amprenavir—Pruritus—Fluorouracil—head and neck cancer	0.000225	0.007	CcSEcCtD
Amprenavir—Skin disorder—Docetaxel—head and neck cancer	0.000223	0.00694	CcSEcCtD
Amprenavir—Anorexia—Docetaxel—head and neck cancer	0.000219	0.00681	CcSEcCtD
Amprenavir—Diarrhoea—Fluorouracil—head and neck cancer	0.000218	0.00677	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000209	0.00651	CcSEcCtD
Amprenavir—Paraesthesia—Docetaxel—head and neck cancer	0.000206	0.00642	CcSEcCtD
Amprenavir—Vomiting—Fluorouracil—head and neck cancer	0.000202	0.00629	CcSEcCtD
Amprenavir—Rash—Fluorouracil—head and neck cancer	0.000201	0.00624	CcSEcCtD
Amprenavir—Dermatitis—Fluorouracil—head and neck cancer	0.0002	0.00624	CcSEcCtD
Amprenavir—Decreased appetite—Docetaxel—head and neck cancer	0.0002	0.00621	CcSEcCtD
Amprenavir—Headache—Fluorouracil—head and neck cancer	0.000199	0.0062	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000198	0.00617	CcSEcCtD
Amprenavir—Fatigue—Docetaxel—head and neck cancer	0.000198	0.00616	CcSEcCtD
Amprenavir—Nausea—Fluorouracil—head and neck cancer	0.000189	0.00588	CcSEcCtD
Amprenavir—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000188	0.00584	CcSEcCtD
Amprenavir—Abdominal pain—Docetaxel—head and neck cancer	0.000182	0.00565	CcSEcCtD
Amprenavir—ABCC1—S1P1 pathway—MAPK1—head and neck cancer	0.000169	0.0116	CbGpPWpGaD
Amprenavir—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000165	0.0114	CbGpPWpGaD
Amprenavir—Asthenia—Docetaxel—head and neck cancer	0.000165	0.00513	CcSEcCtD
Amprenavir—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000164	0.0113	CbGpPWpGaD
Amprenavir—Pruritus—Docetaxel—head and neck cancer	0.000163	0.00505	CcSEcCtD
Amprenavir—Diarrhoea—Docetaxel—head and neck cancer	0.000157	0.00489	CcSEcCtD
Amprenavir—Vomiting—Docetaxel—head and neck cancer	0.000146	0.00454	CcSEcCtD
Amprenavir—Rash—Docetaxel—head and neck cancer	0.000145	0.0045	CcSEcCtD
Amprenavir—Dermatitis—Docetaxel—head and neck cancer	0.000145	0.0045	CcSEcCtD
Amprenavir—Headache—Docetaxel—head and neck cancer	0.000144	0.00448	CcSEcCtD
Amprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000144	0.0099	CbGpPWpGaD
Amprenavir—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000139	0.00957	CbGpPWpGaD
Amprenavir—Nausea—Docetaxel—head and neck cancer	0.000136	0.00424	CcSEcCtD
Amprenavir—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000134	0.00926	CbGpPWpGaD
Amprenavir—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000129	0.00889	CbGpPWpGaD
Amprenavir—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000128	0.0088	CbGpPWpGaD
Amprenavir—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000122	0.00843	CbGpPWpGaD
Amprenavir—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000112	0.00775	CbGpPWpGaD
Amprenavir—ABCC1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.00011	0.00755	CbGpPWpGaD
Amprenavir—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000108	0.00745	CbGpPWpGaD
Amprenavir—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000103	0.00708	CbGpPWpGaD
Amprenavir—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000102	0.00701	CbGpPWpGaD
Amprenavir—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000101	0.00699	CbGpPWpGaD
Amprenavir—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000101	0.00694	CbGpPWpGaD
Amprenavir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.0001	0.00692	CbGpPWpGaD
Amprenavir—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	9.91e-05	0.00683	CbGpPWpGaD
Amprenavir—CYP2B6—Biological oxidations—NAT2—head and neck cancer	9.45e-05	0.00651	CbGpPWpGaD
Amprenavir—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	9.32e-05	0.00642	CbGpPWpGaD
Amprenavir—CYP3A5—Biological oxidations—NAT2—head and neck cancer	9.24e-05	0.00637	CbGpPWpGaD
Amprenavir—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	9.11e-05	0.00628	CbGpPWpGaD
Amprenavir—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	9.08e-05	0.00625	CbGpPWpGaD
Amprenavir—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	8.98e-05	0.00619	CbGpPWpGaD
Amprenavir—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	8.7e-05	0.00599	CbGpPWpGaD
Amprenavir—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	8.59e-05	0.00592	CbGpPWpGaD
Amprenavir—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	8.33e-05	0.00574	CbGpPWpGaD
Amprenavir—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	8.28e-05	0.0057	CbGpPWpGaD
Amprenavir—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	8.19e-05	0.00564	CbGpPWpGaD
Amprenavir—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	8.14e-05	0.00561	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—NAT2—head and neck cancer	8e-05	0.00551	CbGpPWpGaD
Amprenavir—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	7.89e-05	0.00544	CbGpPWpGaD
Amprenavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.77e-05	0.00535	CbGpPWpGaD
Amprenavir—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.66e-05	0.00528	CbGpPWpGaD
Amprenavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.14e-05	0.00492	CbGpPWpGaD
Amprenavir—CYP2C19—Biological oxidations—NAT2—head and neck cancer	7.14e-05	0.00492	CbGpPWpGaD
Amprenavir—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.08e-05	0.00488	CbGpPWpGaD
Amprenavir—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.05e-05	0.00486	CbGpPWpGaD
Amprenavir—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.05e-05	0.00486	CbGpPWpGaD
Amprenavir—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	7.04e-05	0.00485	CbGpPWpGaD
Amprenavir—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	7.04e-05	0.00485	CbGpPWpGaD
Amprenavir—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	6.99e-05	0.00481	CbGpPWpGaD
Amprenavir—ABCC1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	6.77e-05	0.00466	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—NAT2—head and neck cancer	6.57e-05	0.00453	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—NAT2—head and neck cancer	6.51e-05	0.00449	CbGpPWpGaD
Amprenavir—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	6.48e-05	0.00446	CbGpPWpGaD
Amprenavir—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	6.42e-05	0.00443	CbGpPWpGaD
Amprenavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.29e-05	0.00434	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—UROD—head and neck cancer	6.03e-05	0.00416	CbGpPWpGaD
Amprenavir—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	5.99e-05	0.00412	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	5.86e-05	0.00404	CbGpPWpGaD
Amprenavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.79e-05	0.00399	CbGpPWpGaD
Amprenavir—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	5.78e-05	0.00398	CbGpPWpGaD
Amprenavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.74e-05	0.00396	CbGpPWpGaD
Amprenavir—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	5.34e-05	0.00368	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	5.33e-05	0.00368	CbGpPWpGaD
Amprenavir—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	4.87e-05	0.00336	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.68e-05	0.00323	CbGpPWpGaD
Amprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.67e-05	0.00322	CbGpPWpGaD
Amprenavir—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	4.67e-05	0.00322	CbGpPWpGaD
Amprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	4.61e-05	0.00318	CbGpPWpGaD
Amprenavir—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	4.6e-05	0.00317	CbGpPWpGaD
Amprenavir—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	4.56e-05	0.00314	CbGpPWpGaD
Amprenavir—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	4.5e-05	0.0031	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—CASP8—head and neck cancer	4.44e-05	0.00306	CbGpPWpGaD
Amprenavir—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	4.43e-05	0.00305	CbGpPWpGaD
Amprenavir—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	4.36e-05	0.00301	CbGpPWpGaD
Amprenavir—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	4.33e-05	0.00298	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—NAT2—head and neck cancer	4.29e-05	0.00296	CbGpPWpGaD
Amprenavir—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	4.27e-05	0.00294	CbGpPWpGaD
Amprenavir—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	4.24e-05	0.00292	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	3.95e-05	0.00272	CbGpPWpGaD
Amprenavir—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	3.9e-05	0.00269	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—UROD—head and neck cancer	3.89e-05	0.00268	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—UROD—head and neck cancer	3.8e-05	0.00262	CbGpPWpGaD
Amprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	3.79e-05	0.00261	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	3.75e-05	0.00258	CbGpPWpGaD
Amprenavir—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	3.69e-05	0.00255	CbGpPWpGaD
Amprenavir—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	3.53e-05	0.00243	CbGpPWpGaD
Amprenavir—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	3.48e-05	0.0024	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—IL2—head and neck cancer	3.35e-05	0.00231	CbGpPWpGaD
Amprenavir—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	3.34e-05	0.0023	CbGpPWpGaD
Amprenavir—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	3.3e-05	0.00227	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—UROD—head and neck cancer	3.3e-05	0.00227	CbGpPWpGaD
Amprenavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	3.29e-05	0.00227	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	3.24e-05	0.00224	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	3.22e-05	0.00222	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	3.22e-05	0.00222	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	3.2e-05	0.00221	CbGpPWpGaD
Amprenavir—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	3.2e-05	0.0022	CbGpPWpGaD
Amprenavir—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	3.17e-05	0.00219	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	3.08e-05	0.00212	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	3.05e-05	0.0021	CbGpPWpGaD
Amprenavir—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	3.03e-05	0.00209	CbGpPWpGaD
Amprenavir—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	3.01e-05	0.00207	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—UROD—head and neck cancer	2.94e-05	0.00203	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—UROD—head and neck cancer	2.87e-05	0.00198	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	2.85e-05	0.00196	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—UROD—head and neck cancer	2.71e-05	0.00186	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—UROD—head and neck cancer	2.68e-05	0.00185	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.66e-05	0.00183	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.63e-05	0.00182	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.56e-05	0.00176	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—NAT2—head and neck cancer	2.51e-05	0.00173	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.28e-05	0.00157	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—DPYD—head and neck cancer	2.2e-05	0.00151	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	2.19e-05	0.00151	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	2.12e-05	0.00146	CbGpPWpGaD
Amprenavir—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	2.1e-05	0.00145	CbGpPWpGaD
Amprenavir—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	2.09e-05	0.00144	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—YAP1—head and neck cancer	2.09e-05	0.00144	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.08e-05	0.00143	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	2.01e-05	0.00139	CbGpPWpGaD
Amprenavir—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.98e-05	0.00137	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.88e-05	0.00129	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	1.78e-05	0.00123	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—UROD—head and neck cancer	1.77e-05	0.00122	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NAT2—head and neck cancer	1.62e-05	0.00111	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.61e-05	0.00111	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NAT2—head and neck cancer	1.58e-05	0.00109	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.57e-05	0.00108	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.56e-05	0.00107	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.45e-05	0.001	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.44e-05	0.000991	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—DPYD—head and neck cancer	1.42e-05	0.000977	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.41e-05	0.000969	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—DPYD—head and neck cancer	1.39e-05	0.000955	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NAT2—head and neck cancer	1.37e-05	0.000943	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.37e-05	0.000941	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—YAP1—head and neck cancer	1.34e-05	0.000927	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.33e-05	0.000916	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—YAP1—head and neck cancer	1.31e-05	0.000906	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.3e-05	0.000894	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.28e-05	0.000885	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.27e-05	0.000872	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.27e-05	0.000872	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—TYMS—head and neck cancer	1.25e-05	0.000863	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GSTM1—head and neck cancer	1.24e-05	0.000853	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NAT2—head and neck cancer	1.22e-05	0.000842	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—DPYD—head and neck cancer	1.2e-05	0.000827	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NAT2—head and neck cancer	1.19e-05	0.000821	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GPX1—head and neck cancer	1.19e-05	0.000817	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.18e-05	0.000815	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CYP1A1—head and neck cancer	1.17e-05	0.000808	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.17e-05	0.000807	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—YAP1—head and neck cancer	1.14e-05	0.000785	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NAT2—head and neck cancer	1.12e-05	0.000774	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NOTCH1—head and neck cancer	1.12e-05	0.000773	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NAT2—head and neck cancer	1.11e-05	0.000767	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.1e-05	0.000757	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—DPYD—head and neck cancer	1.07e-05	0.000738	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.06e-05	0.000732	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—DPYD—head and neck cancer	1.05e-05	0.00072	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—YAP1—head and neck cancer	1.02e-05	0.0007	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—YAP1—head and neck cancer	9.92e-06	0.000684	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—DPYD—head and neck cancer	9.85e-06	0.000679	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—DPYD—head and neck cancer	9.77e-06	0.000673	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.64e-06	0.000664	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—YAP1—head and neck cancer	9.35e-06	0.000644	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—YAP1—head and neck cancer	9.27e-06	0.000639	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	8.97e-06	0.000618	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.56e-06	0.000589	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTGS2—head and neck cancer	8.33e-06	0.000574	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—TYMS—head and neck cancer	8.08e-06	0.000556	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTM1—head and neck cancer	7.98e-06	0.00055	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—TYMS—head and neck cancer	7.89e-06	0.000544	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTM1—head and neck cancer	7.8e-06	0.000538	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GPX1—head and neck cancer	7.64e-06	0.000527	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.64e-06	0.000526	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP1A1—head and neck cancer	7.57e-06	0.000521	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GPX1—head and neck cancer	7.47e-06	0.000515	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.46e-06	0.000514	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP1A1—head and neck cancer	7.4e-06	0.00051	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NAT2—head and neck cancer	7.34e-06	0.000506	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTEN—head and neck cancer	7.27e-06	0.000501	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTGS2—head and neck cancer	6.98e-06	0.000481	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.96e-06	0.00048	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—TYMS—head and neck cancer	6.84e-06	0.000471	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTM1—head and neck cancer	6.76e-06	0.000466	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.66e-06	0.000459	CbGpPWpGaD
Amprenavir—ABCC1—Disease—STAT3—head and neck cancer	6.5e-06	0.000448	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GPX1—head and neck cancer	6.47e-06	0.000446	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—DPYD—head and neck cancer	6.44e-06	0.000444	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP1A1—head and neck cancer	6.41e-06	0.000441	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MAPK3—head and neck cancer	6.21e-06	0.000428	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—YAP1—head and neck cancer	6.11e-06	0.000421	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—TYMS—head and neck cancer	6.1e-06	0.000421	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTEN—head and neck cancer	6.08e-06	0.000419	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.07e-06	0.000418	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTM1—head and neck cancer	6.03e-06	0.000416	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—TYMS—head and neck cancer	5.96e-06	0.00041	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MAPK1—head and neck cancer	5.91e-06	0.000407	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EGFR—head and neck cancer	5.91e-06	0.000407	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTM1—head and neck cancer	5.89e-06	0.000406	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GPX1—head and neck cancer	5.78e-06	0.000398	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP1A1—head and neck cancer	5.72e-06	0.000394	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GPX1—head and neck cancer	5.64e-06	0.000389	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—TYMS—head and neck cancer	5.61e-06	0.000387	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP1A1—head and neck cancer	5.58e-06	0.000385	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—TYMS—head and neck cancer	5.56e-06	0.000383	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTM1—head and neck cancer	5.55e-06	0.000382	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTM1—head and neck cancer	5.5e-06	0.000379	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GPX1—head and neck cancer	5.31e-06	0.000366	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GPX1—head and neck cancer	5.27e-06	0.000363	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.26e-06	0.000363	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP1A1—head and neck cancer	5.26e-06	0.000362	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP1A1—head and neck cancer	5.21e-06	0.000359	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3CA—head and neck cancer	5.13e-06	0.000353	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HRAS—head and neck cancer	4.74e-06	0.000327	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.7e-06	0.000324	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS2—head and neck cancer	4.5e-06	0.00031	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS2—head and neck cancer	4.4e-06	0.000303	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CA—head and neck cancer	4.29e-06	0.000296	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.28e-06	0.000295	CbGpPWpGaD
Amprenavir—ABCC1—Disease—AKT1—head and neck cancer	4.19e-06	0.000289	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTEN—head and neck cancer	3.92e-06	0.00027	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTEN—head and neck cancer	3.84e-06	0.000264	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS2—head and neck cancer	3.81e-06	0.000263	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—TYMS—head and neck cancer	3.67e-06	0.000253	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTM1—head and neck cancer	3.63e-06	0.00025	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—AKT1—head and neck cancer	3.51e-06	0.000242	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GPX1—head and neck cancer	3.47e-06	0.000239	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.44e-06	0.000237	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS2—head and neck cancer	3.4e-06	0.000234	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTEN—head and neck cancer	3.32e-06	0.000229	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS2—head and neck cancer	3.32e-06	0.000229	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS2—head and neck cancer	3.13e-06	0.000216	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS2—head and neck cancer	3.1e-06	0.000214	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTEN—head and neck cancer	2.97e-06	0.000204	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTEN—head and neck cancer	2.89e-06	0.000199	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CA—head and neck cancer	2.77e-06	0.000191	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTEN—head and neck cancer	2.73e-06	0.000188	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CA—head and neck cancer	2.71e-06	0.000186	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTEN—head and neck cancer	2.7e-06	0.000186	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CA—head and neck cancer	2.34e-06	0.000162	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—AKT1—head and neck cancer	2.26e-06	0.000156	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—AKT1—head and neck cancer	2.21e-06	0.000152	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CA—head and neck cancer	2.09e-06	0.000144	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.04e-06	0.000141	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.04e-06	0.000141	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.92e-06	0.000133	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—AKT1—head and neck cancer	1.91e-06	0.000132	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.91e-06	0.000131	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTEN—head and neck cancer	1.78e-06	0.000123	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—AKT1—head and neck cancer	1.71e-06	0.000118	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—AKT1—head and neck cancer	1.67e-06	0.000115	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—AKT1—head and neck cancer	1.57e-06	0.000108	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—AKT1—head and neck cancer	1.56e-06	0.000107	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.26e-06	8.67e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—AKT1—head and neck cancer	1.03e-06	7.08e-05	CbGpPWpGaD
